Fulgent Genetics, Inc.
FLGT
$18.50
$0.191.04%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -14.64% | -0.87% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -14.64% | -0.87% | |||
| Cost of Revenue | -2.18% | 4.52% | |||
| Gross Profit | -34.04% | -8.25% | |||
| SG&A Expenses | -26.42% | 44.95% | |||
| Depreciation & Amortization | 0.25% | 0.05% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -12.32% | 18.34% | |||
| Operating Income | 6.68% | -123.54% | |||
| Income Before Tax | 11.26% | -289.85% | |||
| Income Tax Expenses | 87.48% | -723.43% | |||
| Earnings from Continuing Operations | -6.87% | -246.47% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 93.10% | 6.42% | |||
| Net Income | -6.01% | -254.39% | |||
| EBIT | 6.68% | -123.54% | |||
| EBITDA | 7.73% | -202.86% | |||
| EPS Basic | -6.35% | -251.74% | |||
| Normalized Basic EPS | 15.74% | -274.09% | |||
| EPS Diluted | -6.10% | -252.58% | |||
| Normalized Diluted EPS | 15.74% | -274.09% | |||
| Average Basic Shares Outstanding | -0.32% | 0.75% | |||
| Average Diluted Shares Outstanding | -0.32% | 0.75% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||